Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Momentum | Price | Volume | Vol 1d % | SMA 10 | SMA 20 | SMA 50 | SMA 100 | SMA 200 | RSI | Stochastic %K | Stochastic %D | StochRSI %K | StochRSI %D | MACD | MACD Signal | MACD Histogram | Beta |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CORT | CORCEPT THERAPEUTICS INC | $90.21 | 772,000 | -25.55% | 84.66 | 81.89 | 66.34 | 52.23 | 60.59 | 80.64 | 85.91 | 87.21 | 49.55 | 50.34 | 6.28 | 6.37 | -0.09 | 0.99 | ||
| LQDA | LIQUIDIA CORP | $78.93 | 1,406,000 | 7.33% | 76.43 | 71.66 | 58.83 | 47.67 | 39.12 | 69.46 | 90.86 | 88.52 | 44.66 | 42.26 | 5.72 | 5.62 | 0.10 | 1.04 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $312.78 | 1,093,000 | 4.59% | 294.03 | 292.64 | 295.83 | 309.19 | 366.93 | 64.13 | 87.00 | 79.82 | 100.00 | 97.57 | 1.44 | -1.45 | 2.89 | 0.89 | ||
| XERS | XERIS BIOPHARMA HOLDINGS INC | $8.28 | 3,753,000 | 37.98% | 7.55 | 7.08 | 6.55 | 6.31 | 7.04 | 83.56 | 92.84 | 93.80 | 100.00 | 100.00 | 0.45 | 0.33 | 0.12 | 1.23 | ||
| KRYS | KRYSTAL BIOTECH INC | $375.07 | 235,000 | -20.88% | 360.80 | 338.50 | 311.01 | 286.92 | 253.90 | 74.25 | 86.22 | 89.70 | 71.24 | 80.47 | 19.37 | 16.22 | 3.15 | 1.30 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $64.53 | 626,000 | -4.72% | 60.07 | 55.39 | 53.83 | 49.91 | 45.07 | 72.81 | 93.58 | 91.76 | 91.17 | 92.02 | 3.13 | 2.03 | 1.10 | 0.81 | ||
| HALO | HALOZYME THERAPEUTICS INC | $79.45 | 1,566,000 | -1.63% | 73.78 | 72.17 | 69.02 | 68.61 | 69.11 | 72.06 | 92.57 | 92.72 | 91.28 | 94.68 | 2.39 | 1.51 | 0.88 | 0.78 | ||
| VCEL | VERICEL CORP | $46.98 | 641,000 | 4.40% | 43.35 | 40.38 | 36.91 | 35.56 | 35.93 | 77.15 | 87.50 | 85.56 | 62.46 | 65.38 | 2.76 | 2.13 | 0.63 | 1.46 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $58.99 | 1,484,000 | 1.64% | 57.25 | 56.68 | 54.72 | 56.33 | 55.74 | 61.82 | 68.06 | 65.11 | 61.21 | 60.06 | 0.97 | 0.78 | 0.19 | 0.71 | ||
| RPRX | ROYALTY PHARMA PLC | $57.77 | 3,245,000 | 34.42% | 55.38 | 55.10 | 53.24 | 49.90 | 44.22 | 63.93 | 85.63 | 87.51 | 75.26 | 78.30 | 0.89 | 0.74 | 0.16 | 0.46 | ||
| ADMA | ADMA BIOLOGICS INC | $8.95 | 4,367,000 | 43.70% | 8.60 | 8.43 | 8.83 | 11.10 | 13.98 | 58.28 | 56.70 | 46.81 | 65.02 | 54.50 | 0.00 | -0.08 | 0.08 | 1.20 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $13.98 | 1,422,000 | 29.51% | 13.45 | 12.95 | 11.56 | 10.47 | 9.83 | 65.09 | 77.64 | 81.74 | 62.92 | 73.38 | 0.72 | 0.65 | 0.06 | 0.90 | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $243.47 | 767,000 | -6.46% | 232.66 | 232.36 | 226.48 | 205.48 | 179.78 | 63.22 | 91.35 | 86.57 | 90.97 | 88.54 | 3.03 | 2.12 | 0.91 | 0.70 | ||
| ASND | ASCENDIS PHARMA A | $274.50 | 552,000 | 6.98% | 253.05 | 235.39 | 233.87 | 232.28 | 220.34 | 75.95 | 94.93 | 91.29 | 100.00 | 99.78 | 10.87 | 5.59 | 5.28 | 0.74 | ||
| TGTX | TG THERAPEUTICS INC | $53.31 | 3,076,000 | 54.96% | 54.21 | 50.18 | 43.23 | 37.17 | 34.65 | 68.42 | 68.46 | 78.57 | 11.62 | 41.62 | 3.68 | 3.76 | -0.09 | 1.85 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $37.26 | 1,013,000 | 37.45% | 34.99 | 34.43 | 32.46 | 31.04 | 32.32 | 70.53 | 92.17 | 89.29 | 87.98 | 78.11 | 1.17 | 0.96 | 0.21 | 0.82 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $319.55 | 368,000 | -19.47% | 296.26 | 272.33 | 244.59 | 223.94 | 207.36 | 80.44 | 93.28 | 94.46 | 88.22 | 93.24 | 21.91 | 17.18 | 4.72 | 1.12 | ||
| TECH | BIO-TECHNE CORP | $70.83 | 7,826,000 | -33.77% | 65.38 | 59.69 | 53.95 | 54.89 | 58.08 | 76.62 | 97.86 | 97.97 | 95.26 | 96.78 | 5.21 | 3.72 | 1.49 | 1.15 | ||
| SPRO | SPERO THERAPEUTICS INC | $2.20 | 630,000 | 65.35% | 2.19 | 2.45 | 2.58 | 2.52 | 2.41 | 40.96 | 23.85 | 25.48 | 33.31 | 35.14 | -0.14 | -0.12 | -0.02 | 0.79 | ||
| EXEL | EXELIXIS INC | $55.85 | 2,364,000 | 28.27% | 53.40 | 53.03 | 50.10 | 46.59 | 44.18 | 67.08 | 75.54 | 73.25 | 80.85 | 80.38 | 1.27 | 1.15 | 0.12 | 0.61 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $528.04 | 1,856,000 | 54.28% | 485.60 | 466.08 | 446.92 | 453.57 | 443.88 | 81.04 | 93.33 | 91.22 | 93.63 | 94.72 | 17.70 | 11.62 | 6.08 | 0.57 | ||
| NAGE | NIAGEN BIOSCIENCE INC | $3.43 | 465,000 | -14.99% | 3.37 | 3.41 | 3.87 | 4.34 | 5.70 | 46.08 | 35.40 | 23.62 | 65.70 | 54.50 | -0.13 | -0.16 | 0.02 | 1.50 | ||
| UTHR | UNITED THERAPEUTICS CORP | $555.91 | 534,000 | 30.88% | 544.50 | 546.26 | 559.65 | 544.27 | 504.11 | 54.26 | 62.84 | 51.17 | 83.07 | 72.68 | -2.92 | -4.43 | 1.51 | 0.41 | ||
| CPRX | CATALYST PHARMACEUTICALS INC | $31.45 | 1,616,000 | 106.39% | 31.43 | 31.38 | 30.72 | 27.55 | 24.95 | 70.17 | 63.36 | 70.02 | 6.59 | 14.87 | 0.24 | 0.33 | -0.08 | 1.00 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $654.27 | 1,072,000 | 8.61% | 625.13 | 620.29 | 657.54 | 710.91 | 699.90 | 59.66 | 77.39 | 76.19 | 81.65 | 84.13 | -4.63 | -11.19 | 6.56 | 0.59 | ||
| VCYT | VERACYTE INC | $57.08 | 1,150,000 | -3.69% | 57.23 | 53.09 | 45.16 | 39.51 | 39.61 | 64.31 | 84.15 | 89.45 | 51.93 | 71.24 | 4.05 | 3.83 | 0.22 | 1.90 | ||
| INCY | INCYTE CORP | $116.86 | 2,633,000 | 72.66% | 109.47 | 106.23 | 100.70 | 98.66 | 97.93 | 70.49 | 89.87 | 90.83 | 90.40 | 90.46 | 4.16 | 2.97 | 1.20 | 0.53 | ||
| SRPT | SAREPTA THERAPEUTICS INC | $19.28 | 4,358,000 | 29.51% | 17.45 | 16.61 | 18.06 | 18.58 | 19.70 | 64.26 | 94.02 | 84.39 | 100.00 | 93.08 | 0.15 | -0.25 | 0.40 | 1.07 | ||
| MDXG | MIMEDX GROUP INC | $3.95 | 662,000 | -6.63% | 3.83 | 3.76 | 3.63 | 4.02 | 5.34 | 62.60 | 73.40 | 73.28 | 79.92 | 81.42 | 0.07 | 0.04 | 0.02 | 1.27 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.